BARCELONA, Spain—Switching from more potent antiplatelets to clopidogrel based on the results of platelet function testing shortly after PCI seems to be a viable option in patients with ACS, results ...
Patients on prasugrel therapy have greater platelet inhibition than those taking maintenance doses of clopidogrel and thus require a longer time to return to baseline reactivity after stopping the ...
The global platelet function test market is projected to be valued at USD 1.38 billion in 2025 and is expected to reach USD 2.61 billion by 2035, registering a CAGR of 6.3% during the forecast period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results